Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Clément, Gauvain"'
Autor:
Camille Ardin, Sarah Humez, Vincent Leroy, Alexandre Ampere, Soraya Bordier, Fabienne Escande, Amélie Turlotte, Luc Stoven, David Nunes, Alexis Cortot, Clément Gauvain
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: The optimal duration of immune checkpoint inhibitor (ICI) treatment for patients with advanced non-small cell lung cancer (NSCLC) remains to be determined. Treatment durations in cornerstone phase 3 clinical trials vary between a fixed 2-
Externí odkaz:
https://doaj.org/article/eb9dd7e9b3524025b2ea8b7fb0b18c7d
Autor:
Ferréol Roborel de Climens, MD, Christos Chouaid, MD, PhD, Claire Poulet, MD, Vincent Leroy, MD, Luc Stoven, MD, Alexis Benjamin Cortot, MD, PhD, Xavier Dhalluin, MD, Clément Gauvain, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 5, Pp 100147- (2021)
Introduction: It is not known whether patients with NSCLC who are hospitalized because of cancer-related complications are liable to benefit from salvage immunotherapy. Methods: This is a multicenter observational study including five centers, which
Externí odkaz:
https://doaj.org/article/c9d83fedf4784a4ea32914fafb24aa29
Autor:
Jean-Baptiste Assié, Florian Crépin, Emmanuel Grolleau, Anthony Canellas, Margaux Geier, Aude Grébert-Manuardi, Nabila Akkache, Aldo Renault, Pierre-Alexandre Hauss, Marielle Sabatini, Valentine Bonnefoy, Alexis Cortot, Marie Wislez, Clément Gauvain, Christos Chouaïd, Arnaud Scherpereel, Isabelle Monnet
Publikováno v:
Cancers; Volume 14; Issue 6; Pages: 1498
Cancers
Cancers, 2022, 14 (6), pp.1498. ⟨10.3390/cancers14061498⟩
Cancers
Cancers, 2022, 14 (6), pp.1498. ⟨10.3390/cancers14061498⟩
Backgrounds: Malignant pleural mesothelioma (MPM) is a cancer with poor prognosis. Second-line and onward therapy has many options, including immune-checkpoint inhibitors with demonstrated efficacy: 10–25% objective response rate (ORR) and 40–70%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34e4c77b0aa950957c9b7de7eef6f8f7
Autor:
Quentin, Philippot, Caroline, Kannengiesser, Marie Pierre, Debray, Clément, Gauvain, Ibrahima, Ba, Margherita, Vieri, Anne, Gondouin, Jean-Marc, Naccache, Martine, Reynaud-Gaubert, Yurdagul, Uzunhan, Benjamin, Bondue, Dominique, Israël-Biet, Philippe, Dieudé, Cécile, Fourrage, Elodie, Lainey, Effrosyne, Manali, Spyros, Papiris, Lidwine, Wemeau, Sandrine, Hirschi, Hervé, Mal, Hilario, Nunes, Frédéric, Schlemmer, Elodie, Blanchard, Fabian, Beier, Vincent, Cottin, Bruno, Crestani, Raphaël, Borie
Publikováno v:
Respirology (Carlton, Vic.)REFERENCES. 27(3)
Poly(A)-specific ribonuclease (PARN) mutations have been associated with familial pulmonary fibrosis. This study aims to describe the phenotype of patients with interstitial lung disease (ILD) and heterozygous PARN mutations.We performed a retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8501f62b582b497ace869cf4558cf2d
https://pubmed.ncbi.nlm.nih.gov/34981600
https://pubmed.ncbi.nlm.nih.gov/34981600
Autor:
Vivien, Béziat, Simon J, Tavernier, Yin-Huai, Chen, Cindy S, Ma, Marie, Materna, Arian, Laurence, Jens, Staal, Dominik, Aschenbrenner, Lisa, Roels, Lisa, Worley, Kathleen, Claes, Lisa, Gartner, Lisa A, Kohn, Marieke, De Bruyne, Klaus, Schmitz-Abe, Louis-Marie, Charbonnier, Sevgi, Keles, Justine, Nammour, Natasha, Vladikine, Majistor Raj Luxman, Maglorius Renkilaraj, Yoann, Seeleuthner, Mélanie, Migaud, Jérémie, Rosain, Mohamed, Jeljeli, Bertrand, Boisson, Eva, Van Braeckel, Jill A, Rosenfeld, Hongzheng, Dai, Lindsay C, Burrage, David R, Murdock, Bart N, Lambrecht, Véronique, Avettand-Fenoel, Tiphanie P, Vogel, Charles R, Esther, Sule, Haskologlu, Figen, Dogu, Peter, Ciznar, David, Boutboul, Marie, Ouachée-Chardin, Jean, Amourette, Marie-Noëlle, Lebras, Clément, Gauvain, Colas, Tcherakian, Aydan, Ikinciogullari, Rudi, Beyaert, Laurent, Abel, Joshua D, Milner, Bodo, Grimbacher, Louis-Jean, Couderc, Manish J, Butte, Alexandra F, Freeman, Émilie, Catherinot, Claire, Fieschi, Talal A, Chatila, Stuart G, Tangye, Holm H, Uhlig, Filomeen, Haerynck, Jean-Laurent, Casanova, Anne, Puel
Publikováno v:
Journal of Experimental Medicine
Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (6), ⟨10.1084/jem.20191804⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (6), ⟨10.1084/jem.20191804⟩
The Journal of Experimental Medicine
International audience; Autosomal dominant hyper-IgE syndrome (AD-HIES) is typically caused by dominant-negative (DN) STAT3 mutations. Patients suffer from cold staphylococcal lesions and mucocutaneous candidiasis, severe allergy, and skeletal abnorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::986f4b8ecddc725ede6ea398366d425a
https://hal.uvsq.fr/hal-02549533
https://hal.uvsq.fr/hal-02549533
Autor:
Christos Chouaid, Alexis B. Cortot, Clément Gauvain, F. Vinas, Isabelle Monnet, Emilie Le Rhun, Laurence Jabot, Arnaud Scherpereel, Enora Vauléon
Publikováno v:
Lung Cancer
Lung Cancer, 2018, 116, pp.62-66. ⟨10.1016/j.lungcan.2017.12.008⟩
Lung Cancer, Elsevier, 2018, 116, pp.62-66. ⟨10.1016/j.lungcan.2017.12.008⟩
Lung Cancer, 2018, 116, pp.62-66. ⟨10.1016/j.lungcan.2017.12.008⟩
Lung Cancer, Elsevier, 2018, 116, pp.62-66. ⟨10.1016/j.lungcan.2017.12.008⟩
International audience; Objectives: Although nivolumab has shown efficacy against non-small-cell lung cancers (NSCLCs), patients with active brain metastases (BMs) were excluded from pivotal clinical trials. Hence, data regarding nivolumab intracereb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26765ff6ec4ea59ed068067f064b6d02
https://doi.org/10.1016/j.lungcan.2017.12.008
https://doi.org/10.1016/j.lungcan.2017.12.008
Autor:
Arturo Londoño-Vallejo, Clément Gauvain, Julie Traclet, Tristan Dégot, Vincent Cottin, Marie Wislez, Raphael Borie, Bruno Crestani, Stéphane Dominique, Lidwine Wemeau-Stervinou, Patrick Revy, Aurélie Cazes, Caroline Kannengiesser, Pierre-Antoine Juge, Hilario Nunes, Christelle Ménard, Diane Bouvry, Catherine Boileau, Jacques Cadranel, Marie-Pierre Debray, Sébastien Quétant, Anne Sophie Gamez, Hervé Mal, Grégoire Prévot, Philippe Dieudé, Madeleine Jaillet, Arnaud Mailleux
Publikováno v:
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2019, 53 (2), pp.1800508. ⟨10.1183/13993003.00508-2018⟩
European Respiratory Journal, European Respiratory Society, 2019, 53 (2), pp.1800508. ⟨10.1183/13993003.00508-2018⟩
Regulator of telomere length 1 (RTEL1) mutations have been evidenced in 5–9% of familial pulmonary fibrosis; however, the phenotype of patients with interstitial lung disease (ILD) and RTEL1 mutations is poorly understood.Whole exome sequencing was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a1a715f395d9d2d2f1aec9f9e3d0cc
https://hal.archives-ouvertes.fr/hal-02347765
https://hal.archives-ouvertes.fr/hal-02347765
Autor:
Alexis Benjamin Cortot, Xavier Dhalluin, Luc Stoven, Clément Gauvain, Ferréol Roborel de Climens, Vincent Leroy, Christos Chouaid, Claire Poulet
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 5, Pp 100147-(2021)
Jto Clinical and Research Reports
Jto Clinical and Research Reports, 2021, 2 (5), pp.100147. ⟨10.1016/j.jtocrr.2021.100147⟩
JTO Clinical and Research Reports
Jto Clinical and Research Reports
Jto Clinical and Research Reports, 2021, 2 (5), pp.100147. ⟨10.1016/j.jtocrr.2021.100147⟩
JTO Clinical and Research Reports
International audience; Introduction: It is not known whether patients with NSCLC who are hospitalized because of cancer-related complications are liable to benefit from salvage immunotherapy.Methods: This is a multicenter observational study includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e633f0dd166ecb1b7712a6ba375e6e
https://doi.org/10.1016/j.jtocrr.2021.100147
https://doi.org/10.1016/j.jtocrr.2021.100147
Autor:
Claire Danel, Raphael Borie, Marie Pierre Debray, Bruno Crestani, Laurent Plantier, Clément Gauvain, Hervé Mal, Camille Taillé, Pauline Pradere, Michel Aubier
Publikováno v:
Chest. 149:767-774
Objective To describe a new entity characterized by airway-centered fibroelastosis. Methods We identified cases with prominent airway-centered elastosis in lung samples, and little or no pleural involvement identified through a pathologic database at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d13b04d07c9ce3fef2b54c8bd76788ca
https://doi.org/10.1016/j.chest.2015.10.065
https://doi.org/10.1016/j.chest.2015.10.065
Autor:
Marc Humbert, Yves Castier, Alice Guyard, David Montani, Peter Dorfmüller, Hervé Mal, G. Dauriat, Gabriel Thabut, Clément Gauvain, Claire Danel, Vincent Bunel
Publikováno v:
Chest
Chest, American College of Chest Physicians, 2019, 156, pp.33-44. ⟨10.1016/j.chest.2019.02.333⟩
Chest, American College of Chest Physicians, 2019, 156, pp.33-44. ⟨10.1016/j.chest.2019.02.333⟩
The development of pulmonary hypertension (PH) during the course of COPD is a well-known phenomenon, with the prevalence depending on the severity of airway obstruction. When mean pulmonary pressure (mPAP) level at rest is ≥ 35 mm Hg or ≥ 25 mm H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acec53b1274a2f4f9b5b767440f49809
https://pubmed.ncbi.nlm.nih.gov/31279376
https://pubmed.ncbi.nlm.nih.gov/31279376